Overview Financials News + Filings IR Vault Key Docs Charts Transactions Ownership Insiders
|
|
Emergent BioSolutions Inc. (EBS)
|
|
| Credit Analysis |
|
|
|
|
Annual | Quarterly |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Short-term debt | 31.6 | 33.8 | 12.9 | 10.1 | | 20.0 | | |
| Long-term debt | 809.4 | 841.0 | 798.4 | 784.5 | 13.5 | 248.1 | 246.9 | 251.0 |
| Total debt | 841.0 | 874.8 | 811.3 | 794.6 | 13.5 | 268.1 | 246.9 | 251.0 |
| Net debt | 264.9 | 253.5 | 643.5 | 682.4 | | | | |
| |
| Debt to EBITDA | 1.6 | 1.5 | 3.6 | 5.2 | 0.1 | 1.9 | 1.4 | 2.1 |
| Net debt to EBITDA | 0.5 | 0.4 | 2.9 | 4.5 | | | | |
| |
| EBITDA interest coverage | 15.1 | 18.5 | 5.9 | 15.4 | 25.3 | 18.9 | 27.1 | 14.8 |
| EBIT interest coverage | 11.5 | 14.9 | 3.0 | 9.1 | 18.8 | 13.9 | 21.7 | 10.8 |
|